Author:
Vivaldi Caterina,Genovesi Virginia,Ugolini Clara,Bernardini Laura,Casadei-Gardini Andrea,Formica Vincenzo,Salani Francesca,Orsi Giulia,Massa Valentina,Cacciato-Insilla Andrea,Caccese Miriam,Cesario Silvia,Andrikou Kalliopi,Graziani Jessica,Campani Daniela,Vasile Enrico,Fontanini Gabriella,Fornaro Lorenzo,Masi Gianluca
Abstract
<b><i>Introduction:</i></b> Mismatch repair (MMR) deficiency represents a biomarker and therapeutic target in various neoplasms, but its role in biliary tract cancers (BTCs) remains misunderstood. <b><i>Methods:</i></b> MMR status was retrospectively assessed using immunohistochemistry in 163-BTCs patients. We identified MMR proficiency (pMMR)/deficiency (dMMR) according to the loss of MMR proteins (MLH1, PMS2, MSH2, MSH6). The primary objective of the study was to assess the incidence of dMMR in BTCs; the secondary purpose was to explore its association with prognosis and clinical features. <b><i>Results:</i></b> dMMR was recorded in 9 patients, and it was strongly associated with mucinous histology (<i>p</i> < 0.01). Regarding the prognostic effect, in 122-radically resected patients, disease-free survival (DFS) resulted significantly shorter in dMMR patients compared to pMMR patients (10.7 vs. 31.3 months, <i>p</i> = 0.025) and so did nodal status (48.2 vs. 15.3 months in N0 vs. N+) (<i>p</i> < 0.01). Moreover, dMMR confirmed its prognostic role in terms of DFS at multivariate analysis (<i>p</i> = 0.03), together with nodal status (<i>p</i> = 0.01), and resection margin (<i>p</i> = 0.03). In 103 M+ patients (encompassing 41 metastatic de novo and 62 recurred after surgery patients) there were not differences between dMMR and pMMR regarding survival analyses. <b><i>Conclusions:</i></b> dMMR status is strongly correlated with mucinous histology and represents an independent prognostic factor in terms of disease relapse in patients with resected BTC. <b><i>Implications for Practice:</i></b> MMR may play an independent role in promoting an aggressive behaviour in patients with radically resected BTC. These results could be useful in improving the selection of patients after resection and, above all, should justify the evaluation of MMR status as a therapeutic target in BTC, especially in patients with atypical histology.
Subject
Cancer Research,Oncology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献